GlaxoSmithKline (GSK) says it is exploding onto the UK energy shots market with a massive £13m marketing investment to support the launch of Lucozade Alert Plus. Developed specifically for UK consumers and underpinned by GSK’s extensive soft drinks expertise and market credibility, the company says Lucozade Alert Plus will be ...